Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Halozyme Therapeutics is 77 — signals lean bullish heading into the print. Underlying trend: 3 of 5 tracked signals trending up over the last 3 months.
Halozyme Therapeutics (HALO) is trading at $102.62, up 46.5% over the last 3 months (from $70.03 three months ago).
Trends across the last 3 months — the run-up to Halozyme Therapeutics’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 14 | ↑ +16.7% |
| LinkedIn headcount | 538 | → +1.9% |
| Web traffic | 12,321 | ↑ +38.1% |
| Employee business outlook | 81% Strongly positive | ↑ +5pp |
| X followers | 701 | → +2.3% |
Full daily-resolution trend charts on every signal are on the HALO ticker page.
AltIndex stock alerts fire when alt-data on HALO breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Halozyme Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log in